Mobic Side Effects

Generic Name: meloxicam

Please note - some side effects for Mobic may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Side Effects of Mobic - for the Consumer

Mobic

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Mobic:

Constipation; diarrhea; dizziness; gas; headache; heartburn; mild stomach pain; nausea; stomach upset; trouble sleeping; vomiting.

Severe allergic reactions (rash; hives; itching; trouble breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; unusual hoarseness); bloody or black, tarry stools; change in the amount of urine produced; chest pain; confusion; dark urine; difficult or painful urination; fainting; fast or irregular heartbeat; fever, chills, or persistent sore throat; loss of appetite; mental or mood changes (eg, depression); numbness of an arm or leg; one-sided weakness; pale stools; red, swollen, blistered, or peeling skin; ringing in the ears; seizures; severe or persistent headache or dizziness; severe or persistent stomach pain or nausea; severe vomiting; shortness of breath; sudden or unexplained weight gain; swelling of hands, legs, or feet; unusual bruising or bleeding; unusual joint or muscle pain; unusual tiredness or weakness; vision or speech changes; vomit that looks like coffee grounds; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

Mobic Suspension

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Mobic Suspension:

Constipation; diarrhea; dizziness; gas; headache; heartburn; mild stomach pain; nausea; stomach upset; trouble sleeping; vomiting.

Severe allergic reactions (rash; hives; itching; trouble breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; unusual hoarseness); bloody or black, tarry stools; change in the amount of urine produced; chest pain; confusion; dark urine; difficult or painful urination; fainting; fast or irregular heartbeat; fever, chills, or persistent sore throat; loss of appetite; mental or mood changes (eg, depression); numbness of an arm or leg; one-sided weakness; pale stools; red, swollen, blistered, or peeling skin; ringing in the ears; seizures; severe or persistent headache or dizziness; severe or persistent stomach pain or nausea; severe vomiting; shortness of breath; sudden or unexplained weight gain; swelling of hands, legs, or feet; unusual bruising or bleeding; unusual joint or muscle pain; unusual tiredness or weakness; vision or speech changes; vomit that looks like coffee grounds; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

Side Effects by Body System - for Healthcare Professionals

Gastrointestinal

Flatulence and dyspepsia were either as common or more frequent among placebo patients. Gastrointestinal side effects have been the most frequently reported adverse events from over 10 placebo-controlled trials with patients with osteoarthritis.

Gastrointestinal (GI) side effects have included abdominal pain in 2% to 5%, constipation in 1% to 3%, diarrhea in 2% to 6%, dyspepsia in 4% to 10%, flatulence in 1% to 3%, nausea in 2% to 7%, and vomiting in up to 3% of patients. Other GI side effects reported in less than 2% of patients have included colitis, dry mouth, duodenal ulcer, eructation, esophagitis, gastric ulcer, gastritis, gastroesophageal reflux, gastrointestinal hemorrhage, hematemesis, hemorrhagic perforation, melena, pancreatitis, perforated duodenal ulcer, perforated gastric ulcer, and ulcerative stomatitis.

Nervous system

Nervous system side effects have included headache (2% to 8%), dizziness (1% to 3%), and insomnia (0% to 4%). Nervous system side effects reported in less than 2% of treated patients have included convulsions, paresthesia, tremor, vertigo, abnormal vision, conjunctivitis, taste perversion, and tinnitus.

Cardiovascular

Cardiovascular side effects have included edema which has been reported by approximately 1% to 5% of patients involved in studies. Other cardiovascular side effects have included angina pectoris, cardiac failure, hypertension, hypotension, myocardial infarction, vasculitis, arrhythmia, dehydration or decreased intravascular volume, palpitations, and tachycardia.

Respiratory

Respiratory system side effects have included cough in up to 2% and pharyngitis or upper respiratory infection in up to 8% of patients. The incidence of infection was similar in some studies among placebo patients or patients taking another NSAID. A causal relationship was not established. Respiratory system side effects in less than 2% of patients have included asthma, bronchospasm, and dyspnea.

Dermatologic

Dermatologic side effects have included rash (1% to 3%) and pruritus in up to 2% of patients. Dermatologic side effects observed in less than 2% of patients have included alopecia, angioedema, bullous eruption, erythema multiforme, photosensitivity reaction, pruritus, Stevens-Johnson syndrome, increased sweating, toxic epidermal necrolysis, and urticaria.

Hematologic

Hematologic side effects have included anemia (reported in more than 2% of patients, but only in some studies.) The incidence has ranged from 0.1% to 4%. Stool sampling for blood loss was not reported in these studies. Other hematologic side effects have included agranulocytosis, leukopenia, purpura, and thrombocytopenia.

Musculoskeletal

Musculoskeletal side effects have included arthralgias in up to 5% and back pain in up to 3% of patients. (The underlying condition of test patients was osteoarthritis.)

Genitourinary

Genitourinary side effects have included new urinary tract infections in up to 7% of patients (it has been the only genitourinary complaint reported in at least 2% of patients.) Hematuria has been associated with the use of meloxicam in less than 2% of patients. Acute urinary retention has been reported in less than 0.1% of patients in postmarketing experience.

Hypersensitivity

Hypersensitivity reactions have included anaphylactic shock, facial edema, fever, hot flashes, syncope, fatigue, and malaise.

Hepatic

Hepatic side effects have been rarely reported (2% or less). These have included, increased serum enzymes (ALT, AST, and GGT), bilirubinemia, hepatitis, jaundice, and liver failure.

Psychiatric

Psychiatric side effects have included abnormal dreaming, anxiety, confusion, depression, nervousness, and somnolence.

Renal

Renal side effects have included urinary frequency, albuminuria, increased BUN, increased serum creatinine, hematuria, interstitial nephritis, and renal failure. New or worsened renal insufficiency has been rarely associated with the use of meloxicam (less than 2% of treated patients).

Other

Other side effects including household accident have been reported in greater than or equal to 2% of patients.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.